MONDAY, Sept. 26, 2022 (HealthDay News) -- Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced renal cell carcinoma (aRCC) of intermediate or poor risk, according to a study presented at the annual meeting of the European Society for Medical Oncology, held from Sept. 9 to 13 in Paris.
MONDAY, Sept. 26, 2022 (HealthDay News) -- Low-income cancer survivors have increased odds of fair/poor health, and reduced odds of having health insurance coverage, according to a study published online Sept. 6 in JCO Oncology Practice.
MONDAY, Sept. 26, 2022 (HealthDay News) -- Here's another reason to stay out of jail: New research shows the risk of dying from cancer is sharply higher among those who are behind bars or have been recently released.
There's a big game Friday night. But ratings and districts, in the grand scheme of things, won't mean all that much to two of York's key figures.
THURSDAY, Sept. 22, 2022 (HealthDay News) -- Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online Sept. 15 in JAMA Oncology.
WEDNESDAY, Sept. 21, 2022 (HealthDay News) -- Considerable progress has been made to improve, extend, and save lives of patients with cancer in the last year, according to the 12th annual Cancer Progress Report released by the American Association for Cancer Research (AACR).
MONDAY, Sept. 19, 2022 (HealthDay News) -- Sugar-sweetened beverage (SSB) consumption is associated with increased mortality from specific cancers, according to a study published online Sept. 15 in Cancer Epidemiology, Biomarkers & Prevention.
MONDAY, Sept. 19, 2022 (HealthDay News) -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the September-October issue of Practical Radiation Oncology, recommendations are presented for the use of radiation therapy (RT) in patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse glioma.
FRIDAY, Sept. 16, 2022 (HealthDay News) -- For women with breast cancer, their race may help predict the success of hormone therapy given before surgery.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Among patients with local regionally advanced oral cavity squamous cell carcinoma, rates of postoperative adverse events appear to be similar for those receiving neoadjuvant pembrolizumab or standard-of-care treatment, according to a study published online Aug. 25 in JAMA Otolaryngology-Head & Neck Surgery.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Elective cesarean section (CS) is associated with an increased risk for leukemia in offspring, according to a systematic review and meta-analysis published online Aug. 24 in Hematological Oncology.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- For patients with borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC), preoperative fluorodeoxyglucose positron emission tomography (FDG-PET) may predict pathologic response to neoadjuvant therapy (NAT), according to a study published online Sept. 8 in the Journal of the National Comprehensive Cancer Network.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Oxygen deprivation resulting from obstructive sleep apnea (OSA) is associated with cancer, according to a study presented at the European Respiratory Society International Congress 2022, held from Sept. 4 to 6 in Barcelona, Spain.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- While there’s no cure for lupus and treatments don’t work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus into remission.
THURSDAY, Sept. 15, 2022 (HealthDay News) -- Skin cancer patients appear to fare better if they receive immunotherapy before their cancers are surgically removed, a pair of clinical trials show.
TUESDAY, Sept. 13, 2022 (HealthDay News) -- The costs of cancer treatments increased from 2009 to 2016, with a corresponding increase in out-of-pocket (OOP) costs for privately insured nonelderly adult cancer patients, according to a study published online Sept. 13 in the Journal of the National Cancer Institute.
TUESDAY, Sept. 13, 2022 (HealthDay News) -- President Joe Biden made a renewed push for his cancer moonshot initiative on Monday.
MONDAY, Sept. 12, 2022 (HealthDay News) -- The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 in Gastroenterology.
MONDAY, Sept. 12, 2022 (HealthDay News) -- A single blood test that can screen for more than 50 cancers seems to work fairly well in the real world, a preliminary study reveals.
Between 2011 and 2020, cancer on average claimed just under 3,500 Nebraskans a year, roughly 50 more than died annually from heart disease, CDC data show.
FRIDAY, Sept. 9, 2022 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday warned doctors and their patients about rare cases of squamous cell carcinoma (SCC) and various lymphomas developing in the scar tissue that forms around breast implants. These cancers are different from an earlier FDA warning about Breast Implant-Associated Anaplastic Large Cell Lymphoma.
FRIDAY, Sept. 9, 2022 (HealthDay News) -- Black and Hispanic patients are significantly less likely than White patients to undergo minimally invasive surgery (MIS) for uterine fibroids, according to a study recently published in the Journal of Minimally Invasive Gynecology.
FRIDAY, Sept. 9, 2022 (HealthDay News) -- Lung cancer CT screening scans can catch tumors at an earlier and more treatable stage, a new study indicates.
THURSDAY, Sept. 8, 2022 (HealthDay News) -- Sitting on the couch or behind a desk could be increasing your risk of breast cancer, a new genetics-driven study suggests.